Advertisement
Heart, Lung and Circulation

Position Statement on the Diagnosis and Management of Familial Dilated Cardiomyopathy

      Genetic factors have an important role in the pathogenesis of dilated cardiomyopathy (DCM) and can be a primary cause of disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maron B.J.
        • Towbin J.A.
        • Thiene G.
        • Antzelevitch C.
        • Corrado D.
        • Arnett D.
        • et al.
        Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.
        Circulation. 2006; 113: 1807-1816
        • Mestroni L.
        • Maisch B.
        • McKenna W.J.
        • Schwartz K.
        • Charron P.
        • Rocco C.
        • et al.
        Guidelines for the study of familial dilated cardiomyopathies: Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.
        Eur Heart J. 1999; 20: 92-102
        • Petretta M.
        • Pirozzi F.
        • Sasso L.
        • Paglia A.
        • Bonaduce D.
        Review and meta-analysis of the frequency of familial dilated cardiomyopathy.
        Am J Cardiol. 2011; 108: 1171-1176
        • Nugent A.
        • Daubeney P.E.
        • Chondros P.
        • Carlin J.B.
        • Cheung M.
        • Wilkinson L.C.
        • et al.
        The epidemiology of childhood cardiomyopathy in Australia.
        N Engl J Med. 2003; 348: 1639-1646
        • Herath V.C.
        • Gentles T.L.
        • Skinner J.R.
        Dilated cardiomyopathy in children: review of all presentations to a children’s hospital over a 5-year period and the impact of family cardiac screening.
        J Paediatr Child Health. 2015; 51: 595-599
        • Kushner J.D.
        • Nauman D.
        • Burgess D.
        • Ludwidsen S.
        • Parks S.B.
        • Pantely G.
        • et al.
        Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy.
        J Card Fail. 2006; 12: 422-429
        • Fatkin D.
        • MacRae C.
        • Sasaki T.
        • Wolff M.R.
        • Porcu M.
        • Frenneaux M.
        • et al.
        Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease.
        N Engl J Med. 1999; 341: 1715-1724
        • Van Berlo J.H.
        • de Voogt W.G.
        • van der Kooi A.J.
        • van Tintelen J.P.
        • Bonne G.
        • Yaou R.B.
        • et al.
        Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?.
        J Mol Med. 2005; 83: 79-83
        • Crispell K.A.
        • Wray A.
        • Ni H.
        • Nauman D.J.
        • Hershberger R.E.
        Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.
        J Am Coll Cardiol. 1999; 34: 837-847
        • van Rijsingen I.A.
        • Nannenberg E.A.
        • Arbustini E.
        • Elliott P.M.
        • Mogensen J.
        • Hermans-van Ast J.F.
        • et al.
        Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.
        Eur J Heart Fail. 2013; 15: 376-384
        • Van Spaendonck-Zwarts K.Y.
        • van Tintelen J.P.
        • van Veldhuisen D.J.
        • van der Werf R.
        • Jongbloed J.D.
        • Paulus W.J.
        • et al.
        Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.
        Circulation. 2010; 121: 2169-2175
        • Hershberger R.E.
        • Lindenfeld J.
        • Mestroni L.
        • Seidman C.E.
        • Taylor M.R.
        • Towbin J.A.
        Genetic evaluation of cardiomyopathy – a Heart Failure Society of America Practice Guideline.
        J Card Fail. 2009; 15: 83-97
        • Hazebroek M.R.
        • Moors S.
        • Dennert R.
        • van den Wijngaard A.
        • Krapels I.
        • Hoos M.
        • et al.
        Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification.
        J Am Coll Cardiol. 2015; 66: 1313-1323
        • Broch K.
        • Andreassen A.K.
        • Hopp E.
        • Loren T.P.
        • Scott H.
        • Muller F.
        • et al.
        Results of a comprehensive diagnostic work-up in “idiopathic” dilated cardiomyopathy.
        Open Heart. 2015; 2: e000271
        • Fatkin D.
        • Seidman C.E.
        • Seidman J.G.
        Genetics and disease of ventricular muscle.
        Cold Spring Harb Perspect Med. 2014; 4: a021063
        • Herman D.S.
        • Lam L.
        • Taylor M.R.
        • Wang L.
        • Teekakirikul P.
        • Christodoulou D.
        • et al.
        Truncations of titin causing dilated cardiomyopathy.
        N Engl J Med. 2012; 366: 619-628
        • Roberts A.M.
        • Ware J.S.
        • Herman D.S.
        • Schafer S.
        • Baksi J.
        • Bick A.G.
        • et al.
        Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.
        Sci Transl Med. 2015; 7: 270ra6
        • Fatkin D.
        • Lam L.
        • Herman D.S.
        • Benson C.C.
        • Felkin L.E.
        • Barton P.J.
        • et al.
        Titin truncating mutations: a rare cause of dilated cardiomyopathy in the young.
        Prog Ped Cardiol. 2016; 40: 41-45
        • Ackerman M.J.
        • Priori S.G.
        • Willems S.
        • Berul C.
        • Brugada R.
        • Calkins H.
        • et al.
        HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies.
        Europace. 2011; 13: 1077-1109
        • Hershberger R.E.
        • Parks S.B.
        • Kushner J.D.
        • Li D.
        • Ludwigsen S.
        • Jakobs P.
        • et al.
        Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy.
        Clin Transl Sci. 2008; 1: 21-26
        • Hershberger R.E.
        • Norton N.
        • Morales A.
        • Li D.
        • Siegfried J.D.
        • Gonzalez-Quintana J.
        Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy.
        Circ Cardiovasc Genet. 2010; 3: 155-161
        • Millat G.
        • Bouvagnet P.
        • Chevalier P.
        • Sebbag L.
        • Dulac A.
        • Dauphin C.
        • et al.
        Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.
        Eur J Med Genet. 2011; 54: e570-e575
        • Lakdawala N.K.
        • Funke B.H.
        • Baxter S.
        • Cirino A.L.
        • Roberts A.E.
        • Judge D.P.
        • et al.
        Genetic testing for dilated cardiomyopathy in clinical practice.
        J Card Fail. 2012; 18: 296-303
        • van Spaendonck-Zwarts K.Y.
        • van Rijsingen I.A.
        • van den Berg M.P.
        • Lekanne Deprez R.H.
        • Post J.G.
        • van Mil A.M.
        • et al.
        Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years’ experience.
        Eur J Heart Fail. 2013; 15: 628-636
        • Pugh T.J.
        • Kelly M.A.
        • Gowrisankar S.
        • Hynes E.
        • Seidman M.A.
        • Baxter S.M.
        • et al.
        The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.
        Genet Med. 2014; 16: 601-608
        • Haas J.
        • Frese K.S.
        • Peil B.
        • Kloos W.
        • Keller A.
        • Nietsch R.
        • et al.
        Atlas of the clinical genetics of human dilated cardiomyopathy.
        Eur Heart J. 2015; 36: 1123-1135
        • Churko J.M.
        • Mantalas G.L.
        • Snyder M.P.
        • Wu J.C.
        Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases.
        Circ Res. 2013; 112: 1613-1623
        • Sikkema-Raddatz B.
        • Johansson L.F.
        • de Boer E.N.
        • Almonani R.
        • Boven L.G.
        • van den Berg M.P.
        • et al.
        Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
        Hum Mutat. 2013; 34: 1035-1042
        • Bamshad M.J.
        • Ng S.B.
        • Bigham A.W.
        • Tabor H.K.
        • Emond M.J.
        • Nickerson D.A.
        • et al.
        Exome sequencing as a tool for Mendelian disease gene discovery.
        Nat Rev Genet. 2011; 12: 745-755
        • Drmanac R.
        Medicine. The ultimate genetic test.
        Science. 2012; 336: 1110-1112
        • MacArthur D.G.
        • Balusubramanian S.
        • Frankish A.
        • Huang N.
        • Morris J.
        • Walter K.
        • et al.
        A systematic survey of loss-of-function variants in human protein-coding genes.
        Science. 2012; 335: 823-828
        • Norton N.
        • Robertson P.D.
        • Rieder M.J.
        • Zuchner S.
        • Rampersaud E.
        • Martin E.
        • et al.
        Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era.
        Circ Cardiovasc Genet. 2012; 5: 167-174
        • Golbus J.R.
        • Puckelwartz M.J.
        • Fahrenbach J.P.
        • Dellefave-Castillo L.M.
        • Wolfgeher D.
        • McNally E.M.
        Population-based variation in cardiomyopathy genes.
        Circ Cardiovasc Genet. 2012; 5: 391-399
        • Pan S.
        • Caleshu C.A.
        • Dunn K.E.
        • Foti M.J.
        • Moran M.K.
        • Soyinka O.
        • et al.
        Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation.
        Circ Cardiovasc Genet. 2012; 5: 602-610
        • Meune C.
        • Van Berlo J.H.
        • Anselme F.
        • Bonne G.
        • Pinto Y.M.
        • Duboc D.
        Primary prevention of sudden death in patients with lamin A/C gene mutations.
        N Engl J Med. 2006; 354: 209-210
        • Mann S.A.
        • Castrol M.L.
        • Ohanian M.
        • Guo G.
        • Zodgekar P.
        • Sheu A.
        • et al.
        R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy.
        J Am Coll Cardiol. 2012; 60: 1566-1573
        • Baig M.K.
        • Goldman J.H.
        • Caforio A.L.
        • Coonar A.S.
        • Keeling P.J.
        • McKenna W.J.
        Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease.
        J Am Coll Cardiol. 1998; 31: 195-201
        • McKenna C.J.
        • Sugrue D.D.
        • Kwon H.M.
        • Sangiorgi G.
        • Carlson P.J.
        • Mahon N.
        • et al.
        Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy.
        Am J Cardiol. 1999; 83: 281-283
        • Mahon N.G.
        • Sharma S.
        • Elliott P.M.
        • Baig M.K.
        • Norman M.W.
        • Barbeyto S.
        • et al.
        Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement.
        Heart. 2000; 83: 511-517
        • Mahon N.G.
        • Madden B.P.
        • Caforio A.L.
        • Elliott P.M.
        • Haven A.J.
        • Keogh B.E.
        • et al.
        Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy.
        J Am Coll Cardiol. 2002; 39: 455-462
        • Caforio A.L.
        • Mahon N.G.
        • Baig M.K.
        • Tona F.
        • Murphy R.T.
        • Elliott P.M.
        • et al.
        Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives.
        Circulation. 2007; 115: 76-83
        • Michels V.V.
        • Olson T.M.
        • Miller F.A.
        • Ballman K.V.
        • Rosales A.G.
        • Driscoll D.J.
        Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy.
        Am J Cardiol. 2003; 91: 1389-1392
        • Mahon N.G.
        • Murphy R.T.
        • MacRae C.A.
        • Caforio A.L.
        • Elliott P.M.
        • McKenna W.J.
        Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease.
        Ann Intern Med. 2005; 143: 108-115
        • Fatkin D.
        • Yeoh T.
        • Hayward C.S.
        • Benson V.
        • Sheu A.
        • Richmond Z.
        • et al.
        Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy.
        Circ Cardiovasc Genet. 2011; 4: 342-348